Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

You may be eligible if

• You may be eligible for this study if you are 18 years of age or older and:
• Have UnResectable Stage IIIA or IIIB Non Small Cell Lung Cancer
• Have never had prior chemotherapy with Paclitaxel or Carboplatin
• Have never had prior thoracic radiation therapy (XRT)